Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antiretroviral Agents”

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00703586
What this trial is testing

Study of the Antiviral and Immunological Effects of Intensification of Suppressive Antiretroviral Therapy With Maraviroc

Who this might be right for
HIV Infections
Rockefeller University 8
Large-scale testing (Phase 3)Temporarily pausedNCT00002362
What this trial is testing

A Comparison of Emtricitabine and Abacavir Used in a Three-Drug Combination in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs

Who this might be right for
HIV Infections
Triangle Pharmaceuticals
Large-scale testing (Phase 3)Study completedNCT02489461
What this trial is testing

Efficacy, Safety and Optimal Dose of VM-1500 in Comparison to Efavirenz Added to Standard-of-care Antiretroviral Therapy

Who this might be right for
HIV-1-infection
Viriom 150
Post-approval studies (Phase 4)Ended earlyNCT00661349
What this trial is testing

Trial About Hepatic Security of Antiretroviral Treatment Based on Kaletra Versus Nevirapine in Co-infected HIV/HCV Patients

Who this might be right for
HIV Infections
Germans Trias i Pujol Hospital 9
Large-scale testing (Phase 3)UnknownNCT00332306
What this trial is testing

Safety and Efficacy of Two Once Daily Anti Retroviral Treatment Regimens Along With Anti-tuberculosis Treatment

Who this might be right for
TuberculosisHuman Immunodeficiency Virus Infections
Tuberculosis Research Centre, India 180
Large-scale testing (Phase 3)Study completedNCT01805258
What this trial is testing

Efficacy and Safety of Concomitant Use of Nevirapine and Rifampicin With HIV-TB

Who this might be right for
HIV/TB Co-infection
All India Institute of Medical Sciences 135
Large-scale testing (Phase 3)Study completedNCT00002416
What this trial is testing

Comparing FTC and Lamivudine in HIV-Infected Patients on a Stable Anti-HIV Drug Combination

Who this might be right for
HIV Infections
Triangle Pharmaceuticals 390
Testing effectiveness (Phase 2)Study completedNCT02859558
What this trial is testing

Early ART to Limit Infection and Establishment of Reservoir

Who this might be right for
HIV-1 Infection
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections 195
Testing effectiveness (Phase 2)WithdrawnNCT02176135
What this trial is testing

Oral Auranofin for Reduction of Latent Viral Reservoir in Patients With HIV Infection

Who this might be right for
HIV
Vaccine and Gene Therapy Institute, Florida
Testing effectiveness (Phase 2)Looking for participantsNCT04513626
What this trial is testing

HIV-1 Infected Patients, Phase II Trial, Dual Combination Doravirine/Raltegravir Open Label

Who this might be right for
HIV Infections
Centre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida 150
Not applicableEnded earlyNCT00207948
What this trial is testing

Optimizing Antiretroviral Therapy in HIV-Infected Children and Adolescents

Who this might be right for
HIV Infections
Children's National Research Institute 4
Post-approval studies (Phase 4)Study completedNCT04039217
What this trial is testing

Antiretroviral Therapy (ART) Persistence in Different Body Compartments in HIV Negative MSM

Who this might be right for
ARTHIV
Emory University 20
Large-scale testing (Phase 3)Study completedNCT03227861
What this trial is testing

Evaluate the Efficacy and Safety of (D/C/F/TAF) Once Daily Fixed Dose Combination (FDC) Regimen in Newly Diagnosed, Antiretroviral Treatment-naive Human Immunodeficiency Virus Type 1 (HIV-1) Infected Participants Receiving Care in a Test and Treat Model of Care

Who this might be right for
HIV-1
Janssen Scientific Affairs, LLC 109
Testing effectiveness (Phase 2)Study completedNCT00002162
What this trial is testing

A Randomized, Parallel Arm, Comparative, Open Label, Multicenter Study of the Activity and Safety of Two Formulations of Saquinavir in Combination With Other Antiretroviral Drugs

Who this might be right for
HIV Infections
Hoffmann-La Roche 140
Not applicableStudy completedNCT02058927
What this trial is testing

Immune Reconstitution to Measles Virus of HIV Infected Children in Zambia

Who this might be right for
Measles
University of North Carolina, Chapel Hill 203
Testing effectiveness (Phase 2)Study completedNCT00338767
What this trial is testing

Antidepressant Medication Plus Directly Observed Therapy for Improving Adherence to Antiretroviral Therapy

Who this might be right for
HIV InfectionsDepression
Massachusetts General Hospital 150
Not applicableUnknownNCT01315301
What this trial is testing

Optimal Time to Initiate Antiretroviral Therapy in HIV & TB Coinfected Adults Being Treated for Tuberculosis

Who this might be right for
Acquired Immunodeficiency SyndromeTuberculosis
Karolinska Institutet 450
Not applicableWithdrawnNCT03877536
What this trial is testing

Antiretroviral Therapy for Acute HIV Infection

Who this might be right for
HIV Infections
Henry M. Jackson Foundation for the Advancement of Military Medicine
Not applicableStudy completedNCT01479634
What this trial is testing

Early HIV Therapy in Patients With High CD4 Cell Counts

Who this might be right for
HIV
University of California, San Francisco 279
Not applicableLooking for participantsNCT02761200
What this trial is testing

Post Analytic Treatment Interruption Study

Who this might be right for
HIV
SEARCH Research Foundation 100
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation